We are pleased to invite you to the State-of-the-Art Conference on Gynecology and Oncology, a brand-new type of meeting organized by the Central and Eastern European Gynecologic Oncology Group (CEEGOG). The conference will take place on September 29–30, 2025, in Prague, and will offer not only an excellent educational programme but also a unique opportunity to showcase the dynamic Central and Eastern European region.

The conference will provide a comprehensive overview of the latest recommendations across the entire field – from diagnosis and surgical treatment to systemic therapies and palliative care. Most of the speakers will come from our region east of the German border, offering valuable regional insights.

More information is available on the conference website: www.sago-conference.eu

We look forward to welcoming you all to Prague in September 2025! 

 

We are pleased to invite you to  the next year’s Annual Meeting of our Collaborative Group CEEGOG, which will take place on Friday, May 23, 2025, at the Department of Gynecology, Obstetrics, and Neonatology of the General University Hospital in Prague.

We look forward to the opportunity to meet you all in Prague and kindly ask you to save the date of 23 May 2025. Thank you in advance.

 

The GCIG Fall Meeting was held virtually in split sessions on November 18, November 21, and December 6, 2024. The meeting was shortened, and focused mainly on the concepts of pragmatic trials. Discussions emphasized the urgent need for practical, affordable, and practice-changing real-world clinical trials designed to produce results applicable to the general population rather than idealized patient cohorts. The value of real-world data, routinely collected from diverse sources outside traditional clinical research settings, was underscored.

Several ideas for pragmatic trials were introduced as well. Efforts should focus on collecting only essential patient data for analysis, reducing the volume of the data gathered, and on streamlining research processes. The key research questions include determining the optimal duration of CPi and PARPi treatment, exploring treatment sequencing, and evaluating strategies for treatment de-escalation. A persistent challenge remains that many novel therapeutics, while impactful in driving global practice changes, are unlikely to be accessible across all clinical settings and countries.

The GCIG's vision of ending gynecologic cancer through global, collaborative research must continue to guide these efforts.

The ENGOT GCA workshop held in 13-15 November 2024 in Stresa Italy, was a dynamic and inspiring event that showcased the latest advancements in GO. We enjoyed a series of thought-provoking presentations and interactive discussions, promoting collaboration and sharing best practices. The atmosphere was filled with enthusiasm and a shared vision for the future, leaving me motivated and ready to implement new ideas in my work concerning the interests of patients and CEEGOG. Many thanks. PhD. Dr. MIHAI STANCA, Târgu Mureş, Romania

Amazing meeting with old friends, exchanging knowledge, skills and expertise connection with gynecological cancer trials. There, international mentors, doctors, research shared experiences from around the Europe. Medicine, including the field of oncogynecology, has not stopped, its is progressing and advancing by the day and hours, that’s why its important to rely on research in this direction and master the skills. DINA KURDIANI, MD, PH.D, Tbilisi, Georgia

 

             

 

           

 

The next CEEGOG meeting will be scheduled for May 2025 and held in Prague. At this time, we cannot confirm the exact date, but it will be one of the following dates: 15 MAY, 16 MAY, 22 MAY, 23MAY

Please be so kind and save all those days. We hope to confirm the date of the annual CEEGOG meeting by the end of this year.  

We are pleased to inform you that recently an article summarizing the final results of the CEEGOG ox-01/HE4-FU-OVCA study has been published. The CEEGOG ox-01/HE4-FU-OVCA study was the first CEEGOG study to be proposed and approved, focusing on the role of the HE4 marker in the follow-up of advanced ovarian, fallopian tube, and primary peritoneal cancer. The article was published in the Cancers journal,  and for your reference, is to be found in the CEEGOG Members´ shared area. Once again, we sincerely thank all participating sites for their valuable cooperation in the CEEGOG ox-01 study. It was a great pleasure for us to work with each of you!

The first GCIG Cervical Cancer Consensus Conference which focused on Clinical Research  was held in Dublin in Mid-October 2024. Dr. Zoltán Novák (Hungarian National Oncological Institute, Hungary) and Professor David Cibula (General University Hospital in Prague, the Czech Republic) represented CEEGOG there. The topics for discussions have been divided in four groups, i.e. Diagnosis and Staging, Early Cervical Cancer, Locally Advanced Cervical Cancer and Metastatic and Recurrent Disease. The main points of the consensus conference have been summarised in the statements to be published.

The Fall ENGOT meeting took place in Amsterdam at the end of September last. CEEGOG was represented by its Chairman Prof. David Cibula and the administrative Manager Mrs. Ivana Nohová.

On the first day, the meeting of Operationals and also the strategic meeting were held. At the meeting of the Operationals, we discussed group experience with the CTIS and regulatory authority surveillance which is one of the Sponsor´s responsibilities for each trial. The main discussion aimed at the feedback from the Working groups as defined by the ENGOT Strategic Group last year. As a reminder, those groups deal with the effective coordination and communication, with academic studies promotion, sustainabiility and early development of new drugs, mentoring groups and young investigators, the ENGOT database and relationship with non-European groups. The Update has also been provided by the Contract working group and Budgeting working group.  

The assembly meeting was held on September 27, 2024. From the CEEGOG studies, the update on the SENTIX study was provided.Twelve new trial proposals are currently developing, and each of them is now in a different phase of negotiation with the Pharmaceutical companies and of trial preparation. The CEEGOG members will be informed on each trial once the trial is prepared for country and site selection.  Among the new trial ideas, which were introduced at the ENGOT meeting, it is worth mentioning that CEEGOG has been appointed as the Lead Engot group for the commercial trial entitled AZALEA and sponsored by Abbvie. We look forward to cooperating on this exciting study!

The election of new CEEGOG leadership was conducted at the CEEGOG meeting held in Prague on JUNE 14, 2024. The new CEEGOG leadership consists of the following representatives: Chair DAVID CIBULA (General University Hospital in Prague, Czech Republic); Vice-Chair FILIP FRÜHAUF (General University Hospital in Prague, Czech Republic); Financial Manager ANDREJ COKAN (University Medical Centre Maribor, Slovenia) and Controller ZOLTÁN NOVÁK (Hungarian National Oncological Institute, Hungary).

Article 13 of the CEEGOG Bylaws stipulates the setting up of the Scientific committee consisting of 5 members, each one of them from a different center, representing at least 4 countries. The following representatives were elected to be members of the CEEGOG Scientific committee:

MIHAI CAPILNA (First Obst. and Gyn. Clinic, University of Medicine and Pharmacy Targu Mures, Romania), ANDRAŽ DOVNIK (University Medical Centre Maribor, Slovenia), DINA KURDIANI (Institute of Clinical Oncology, Georgia), MIKULÁŠ REDECHA (Bory Hospital - Penta Hospitals, Slovakia), VLADYSLAV SUKHIN (Grigoriev Institute for Medical Radiology, Kharkov, Ukraine).

Congratulations to the newly elected officers and Scientific committee members!

We hope that CEEGOG under the new leadership, and with the help of the newly elected Scientific members, will continue in its gradual development, and all CEEGOG countries and sites will be involved in our research activities and clinical trials.

This year´s annual CEEGOG meeting was held in Prague, on JUNE 14-15, 2024. 52 participants representing 33 sites from 11 CEEGOG countries attended the meeting.

Apart from electing the new CEEGOG leadership and new members of the Scientific committee, the meeting brought information on the progress of the running ENGOT and CEEGOG studies, and of the studies under preparation, and also about the newly planned ENGOT studies.

A very interesting highlight of the meeting was the part dedicated to country presentations summarizing the status of gynecology oncology care organization, access to innovative treatment, and the readiness for and barriers to conducting academic studies. We would like to express our thanks to Mirela Kekic (Croatia), David Cibula (Czech Republic), Dina Kurdiani (Georgia), Zoltán Novák (Hungary), Igor Aluloski (North Macedonia), Olga Matylevich (Republic of Belarus), Irina Tripac (Republic of Moldova), Mihai Capilna (Romania), Mikuláš Redecha (Slovakia), Andrej Cokan ( Slovenia) and Vladyslav Sukhin (Ukraine) who prepared and delivered the presentations on the situations in their countries.

Four new study proposals were introduced and are expected to be initiated in the CEEGOG countries this year.

Next meeting will be scheduled for MAY or JUNE 2025 according to the preferences of the individual CEEGOG members. Thank you all for attending the meeting and the garden reception, and for your continued support to CEEGOG. 

A short MEETING of the CEEGOG sites will take place during the upcoming ESGO congress in Barcelona.The aim is to briefly discuss collaboration on clinical trials and the cooperation opportunities within CEEGOG/ENGOT/GCIG with you. You are cordially invited to the meeting. We look forward to meeting with all of you in Barcelona!


The MEETING DETAILS are as follows: 

Date: Friday, MARCH 8 

Time: 12.00 pm – 12.40 pm (CET)

Venue: room 122, floor P1 of  Barcelona International Convention Centre - CCIB

Address: Plaça de Willy Brandt, 11-14, 08019 Barcelona

 

  1. Separation of Polish centers from the CEEGOG group
  2. CEEGOG meeting in Istanbul at ESGO congress
  3. Annual CEEGOG mtg in Prague on December 8, 2023
  4. GCIG SPRING meeting in Chicago, May 31 – June 1, 2023
  5. ENGOT Advisory Board, April 2023
  6. ENGOT mtg in Milano, March 9 – 10, 2023
  7. ENGOT-ENYGO-GCA workshop in Malaga, December 8 – 10, 2022
  8. GCIG Autumn meeting, October 25 - 26, 2022
  9. ENGOT meeting in Berlin, October 6 - 7, 2022
  10. CEEGOG meeting in Prague on November 28, 2022